Model Number N LATEX FLC LAMBDA |
Device Problem
Incorrect, Inadequate or Imprecise Result or Readings (1535)
|
Patient Problem
No Clinical Signs, Symptoms or Conditions (4582)
|
Event Date 09/10/2021 |
Event Type
malfunction
|
Event Description
|
An elevated n latex free light chains, type lambda (flc lambda) result was obtained on a patient sample from an atellica ch 930 analyzer.The sample was autodiluted and repeated on the same instrument, recovered higher.These results were not reported to the physician.The customer performed multiple manual dilutions on the same sample and varying results were obtained.Then, the customer ran the sample neat and the sample recovered at 70 mg/l.After, the sample was autodiluted and rerun on the same instrument, recovering at 106.6 mg/l, which was reported to the physician.There are no known reports of patient intervention or adverse health consequences due to the different flc lambda results.
|
|
Manufacturer Narrative
|
Siemens filed mdr 2432235-2021-00239 on 08-oct-2021 against the atellica ch 930 analyzer for this incident.However, due to additional information received on 03-feb-2022, this mdr is being filed against the n latex flc lambda reagent for the same incident.Additional information (03-feb-2022): siemens further investigated the issue.Quality controls (qc) were found to recover above the measurement interval.Siemens observed a trend in which the discordant patient results and qc results for free light chains, type lambda (flc lambda) were flagged with the same result flag of "e521: excess antigen".The result flag is a method specific coding which monitors the absorbance rate prior to the start of the two-point reaction.If the sample absorbance rate exceeds the absorbance rate of the highest concentrated calibrator level, then the sample is flagged for having excess antigen which may impact the accuracy of the result.Siemens completed internal testing to verify the customer's observation.Each combination of n latex flc lambda reagent and n flc standard sl reported at least one flagged replicate which was flagged with "e521: excess antigen".Each sample tested was known to have a concentration below the measurement interval.The testing was able to replicate the observations at the customer site.Siemens is investigating the issue.
|
|
Manufacturer Narrative
|
Siemens filed the initial mdr 9610806-2022-00005 on 11-feb-2022.Additional information (31-mar-2022): siemens healthcare diagnostics has determined that customers may experience an increased rate of flagged flc lambda quality control (qc) and patient sample results when using this assay on the atellica ch 930 analyzer.The flag message on the analyzer is >70 mg/l which indicates "> measuring interval" on the respective quality control or patient results.Typically, the error message appears when the results obtained are found to be above the defined upper measuring limit.Starting march 31, 2022, customer notification pp22-001-a-c.Us was sent to us customers and pp22-001-a-c.Ous was sent to ous customers informing customers of this issue and providing instructions to the customers.The customer notification explains the behavior described above and informs customers of actions to take to allow continued use of the assay.To date, there are no allegations of injury due to the delays.
|
|
Search Alerts/Recalls
|
|